Acetaminophen News and Research

RSS
The pain-reliever acetaminophen (also known as paracetomol) is one of the best-selling over-the-counter medications, used by more than 200 million Americans a year. It is sold under many brand names, including Tylenol, and is an ingredient in nearly 200 medications, both over-the-counter (such as Excedrin, Midol, NyQuil, and Sudafed) and prescription (such as Vicodin).
PSI acquires PEG-based technology

PSI acquires PEG-based technology

Majority of U.S. employers unlikely to cease offering health care benefits to workers

Majority of U.S. employers unlikely to cease offering health care benefits to workers

Investment group acquires Arbor Pharmaceuticals

Investment group acquires Arbor Pharmaceuticals

Checklist to stay healthy and active during summer season

Checklist to stay healthy and active during summer season

Overview of migraine prevalence, causes, treatments and prevention

Overview of migraine prevalence, causes, treatments and prevention

Nippon Shinyaku to market and sell Labopharm's once-daily tramadol in Japan

Nippon Shinyaku to market and sell Labopharm's once-daily tramadol in Japan

Qutenza 8% patch now available for pain associated with PHN: NeurogesX

Qutenza 8% patch now available for pain associated with PHN: NeurogesX

Cumberland Pharmaceuticals submits Acetadote sNDA for non-acetaminophen acute liver failure

Cumberland Pharmaceuticals submits Acetadote sNDA for non-acetaminophen acute liver failure

Analgesics can decrease risk of breast or ovarian cancer

Analgesics can decrease risk of breast or ovarian cancer

Stress fracture: Causes and treatment strategies

Stress fracture: Causes and treatment strategies

Zogenix announces the initiation of pivotal Phase 3 clinical trial with ZX002

Zogenix announces the initiation of pivotal Phase 3 clinical trial with ZX002

Acetaminophen safe and effective for reducing postpartum pain

Acetaminophen safe and effective for reducing postpartum pain

PerkinElmer to highlight new scientific solutions for pharmaceutical laboratories at PITTCON 2010

PerkinElmer to highlight new scientific solutions for pharmaceutical laboratories at PITTCON 2010

Regular use of aspirin, acetaminophen and NSAIDs increases risk of hearing loss in men

Regular use of aspirin, acetaminophen and NSAIDs increases risk of hearing loss in men

Sales revenue from Labopharm's once-daily tramadol increases to $4.7M for fourth-quarter fiscal 2009

Sales revenue from Labopharm's once-daily tramadol increases to $4.7M for fourth-quarter fiscal 2009

Labopharm's public offering underwriters exercise over-allotment option to purchase additional 1.7M units

Labopharm's public offering underwriters exercise over-allotment option to purchase additional 1.7M units

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Labopharm closes previously announced underwritten public offering of 11,764,706 units

Labopharm closes previously announced underwritten public offering of 11,764,706 units

Acute sinus infections always begin as cold

Acute sinus infections always begin as cold

Ibuprofen may reduce risk of Parkinson's disease, says study

Ibuprofen may reduce risk of Parkinson's disease, says study